NDC 59368-385 - Micardis HCT
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-385
- Package NDCs from labels
- 59368-385-01
- Manufacturer
- Praxis, LLC
- Effective date
- 2023-01-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Micardis HCT - Praxis, LLC | Praxis, LLC | 2023-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 89ce2fb1-330c-45f9-bd37-b402feea9378 | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| triamterene and hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 27b8f965-d73f-411c-aae6-bcae6e281113 | 2023-10-23 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | NCS HealthCare of KY, LLC dba Vangard Labs | d6b933c6-f5f8-406a-84d6-b22c6040482a | 2023-10-19 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 24cba606-263f-46dc-a4dc-fddc729c0f4b | 2023-10-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 9dd2f58b-d143-4d0c-a298-6d9390e6187a | 2023-10-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan | TELMISARTAN | Amneal Pharmaceuticals LLC | 20a60231-64f0-4751-aa81-6c0e64334179 | 2023-09-30 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | Modavar Pharmaceuticals LLC | a075633a-2a2a-4e88-8ede-b49a3920a16c | 2023-09-30 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Benazepril Hydrochloride and Hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Glenmark Pharmaceuticals Inc., USA | 51b0aed8-a229-4d2c-8fdf-aa957fddc41b | 2023-09-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan | TELMISARTAN | A-S Medication Solutions | 509cd338-24db-41d1-a115-9dc999170717 | 2023-09-18 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | ba452478-f40c-446e-b61d-388379a55efd | 2023-09-18 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | e80f232c-c1c4-4524-a0a5-d23ee0d1f3b7 | 2023-09-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH U5SYW473RQ |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | b9e1bed7-fef9-434a-92f9-b70941176e3e | 2023-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| triamterene and hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Lifesciences Limited | 1af80800-e7a5-42e5-aa6c-3f61aff4a77b | 2023-08-31 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| triamterene and hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Zydus Pharmaceuticals (USA) Inc. | fa69eeb8-ec82-4be1-8cb7-f64094ed957c | 2023-08-26 | Boxed warning, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 1bb00980-eeea-4722-b010-e208f3ec2214 | 2023-08-24 | Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan | TELMISARTAN | Cadila Pharmaceuticals Limited | 353fcb30-2fa7-4ff1-8a18-26f3ec279d00 | 2023-08-02 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 8d992a4c-8740-4636-928f-bb808eae3336 | 2023-08-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Telmisartan | TELMISARTAN | Amneal Pharmaceuticals of New York LLC | bf2dca37-ce9c-40e4-8ad6-b8186aa7fed1 | 2023-08-01 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Benicar HCT | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | 881a1c32-c209-4038-9c5e-c5e46c6e0546 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Tribenzor | OLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDE | Cosette Pharmaceuticals, Inc. | 2f56d0bc-236b-41a0-9fc0-21cdfea8d890 | 2023-07-12 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.